According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are $45.71 Million USD. In 2023 the company made an earning of -$69.47 Million USD, an increase over its 2022 earnings that were of -$99.07 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -$0.11 Billion | 48.98% |
2023 | -$69.47 Million | -29.88% |
2022 | -$99.07 Million | 87.2% |
2021 | -$52.92 Million | 38.58% |
2020 | -$38.19 Million | -24.56% |
2019 | -$50.62 Million | |
2017 | -$23.09 Million | 22.59% |
2016 | -$18.84 Million | -8.02% |
2015 | -$20.48 Million | -296.09% |
2014 | $10.44 M | -174.02% |
2013 | -$14.11 Million | 37.42% |
2012 | -$10.27 Million | -56.29% |
2011 | -$23.49 Million | -1062.38% |
2010 | $2.44 M | -250.43% |
2009 | -$1.63 Million | -89.5% |
2008 | -$15.46 Million | |
2005 | -$9.53 Million | 56.99% |
2004 | -$6.07 Million | 73.7% |
2003 | -$3.5 Million |